Nucleus
Nucleus to float on London’s AIM in July
Platform provider Nucleus will float on the London Stock Exchange’s Alternative Investment Market (Aim) later this month, in a deal that is expected to value the business at £150m ($198m, €169m).
Best Practice | 15 Mar 18
DB transfers will ‘come to a head’ when stock market falls
When markets fall, consumers who have transferred out of a defined benefit (DB) scheme and started accessing their pots could potentially face a crisis in their retirement, a director from advice firm Tuto Associates has argued.
Investment | 14 Mar 18
What do IPOs mean for the future of platforms?
With a recent spate of initial public offerings (IPOs) and planned listings from Transact, AJ Bell and Nucleus, industry experts share their thoughts on what this means for the future of platforms.
Best Practice | 27 Feb 18
Nucleus launches DB roundtable series
Nucleus, the adviser-built wrap platform, has brought together a panel of experts and financial advisers to help the IFA community navigate its way through the defined benefit (DB) transfer “minefield”.
Best Practice | 19 Feb 18
Nucleus launches capital gains tool
UK adviser-built wrap platform Nucleus has launched a capital gains tax (CGT) tool, Narrate CG.


